Furthermore, in vitro assays of SIRT3 and senescence-related protein expression, along with western blotting, showed that compared with the DCM group, the CVB-D treatment group presented decreased expression of senescence-related proteins and increased expression of SIRT3. Here, SIRT3 is linked to familial dilated cardiomyopathy.